Meeder Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-92
| Closed | -$7K | – | 2699 |
|
|
2021
Q1 | $7K | Buy |
+92
| New | +$7K | ﹤0.01% | 1756 |
|
|
2020
Q4 | – | Sell |
-942
| Closed | -$82K | – | 2281 |
|
|
2020
Q3 | $82K | Buy |
+942
| New | +$82K | 0.01% | 837 |
|
|
2020
Q1 | – | Sell |
-123
| Closed | -$8K | – | 2580 |
|
|
2019
Q4 | $8K | Buy |
123
+104
| +547% | +$6.76K | ﹤0.01% | 1650 |
|
|
2019
Q3 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 2003 |
|
|
2019
Q2 | – | Sell |
-28
| Closed | -$3K | – | 2169 |
|
|
2019
Q1 | $3K | Sell |
28
-31
| -53% | -$3.32K | ﹤0.01% | 1514 |
|
|
2018
Q4 | $3K | Buy |
59
+48
| +436% | +$2.44K | ﹤0.01% | 1534 |
|
|
2018
Q3 | $1K | Sell |
11
-1
| -8% | -$91 | ﹤0.01% | 1501 |
|
|
2018
Q2 | $1.21K | Sell |
12
-2
| -14% | -$201 | ﹤0.01% | 1465 |
|
|
2018
Q1 | $2K | Sell |
14
-21
| -60% | -$3K | ﹤0.01% | 1403 |
|
|
2017
Q4 | $3K | Buy |
35
+30
| +600% | +$2.57K | ﹤0.01% | 1450 |
|
|
2017
Q3 | $1K | Sell |
5
-19
| -79% | -$3.8K | ﹤0.01% | 1574 |
|
|
2017
Q2 | $4K | Hold |
24
| – | – | ﹤0.01% | 1282 |
|
|
2017
Q1 | $4K | Buy |
24
+14
| +140% | +$2.33K | ﹤0.01% | 1191 |
|
|
2016
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 963 |
|